Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
It is currently classified as a research peptide and has not been evaluated by the FDA for safety or efficacy in humans
Moreover, it is noteworthy that nanotechnology offers immense potential in preventing and alleviating PIPN via two main strategies: 1) enhancing the targeting accumulation and/or activity of Pt drugs at tumor tissues while decreasing the off-target effects and 2) specific delivery of antioxidant agents toward the peripheral nervous system
Chang JD, Gao W, Wang P, Zhao FJ
BPC-157, also known as Body Protection Compound-157, is a pentadecapeptide (a 15-amino acid peptide sequence) first described in 1992
US$ 24.45
US$ 24.85
US$ 22.14
US$ 21.41
